Due to large outbreaks observed worldwide, Candida auris has emerged as a major threat to healthcare facilities. To prevent these phenomena, a systematic screening should be performed in patients transferred from regions where the pathogen is highly endemic. In this study, we recorded and analyzed French mycologists' current knowledge and practice regarding C. auris screening and diagnosis. Thirty-six centers answered an online questionnaire. Only 11 (30.6 %) participants were aware of any systematic screening for C. auris for patients admitted to their hospital. In the case of post-admission screening, axillae/groins (n = 21), nares (n = 7), rectum (n = 9), and mouth (n = 6) alone or various combinations were the body sites the most frequently sampled. Only six centers (8.3 %) reported using a commercially available plate allowing the differentiation of C. auris colonies from that of other Candida species, while five laboratories (13.8 %) had implemented a C. auris-specific qPCR. Considering the potential impact on infected patients and the risk of disorganization in the care of patients, it is crucial to remember to biologists and clinicians the utmost importance of systematic screening on admission.
- Current knowledge and practice of Candida auris screening in France: A nationwide survey from the French Society of Medical Mycology (SFMM)
- Juliette Guitard - Sorbonne UniversitéAnne-Pauline Bellanger - Service de parasitologie et mycologie [CHRU de Besançon]Joséphine Dorin - Centre Hospitalier de BigorreSophie Cassaing - Hôpital PurpanAgathe Capitaine - Université de Caen NormandieFrédéric Gabriel - Centre Hospitalier Universitaire de BordeauxMaxime Nicolas - Aix-Marseille UniversitéNoémie Coron - Laboratoire de Chémo-biologie synthétique et thérapeutiquePascale Penn - Centre Hospitalier du MansMaxime Moniot - Centre Hospitalier Universitaire de Clermont-FerrandDorothée QuinioStephane Ranque - Aix-Marseille UniversitéMilène Sasso - Centre National de la Recherche ScientifiquePatrice Le Pape - Cibles et Médicaments des Infections et de l'ImmunitéEric Dannaoui - Hôpital Necker-Enfants MaladesSophie Brun - Hôpital AvicenneClaire Lacroix - Laboratoire Jean PerrinMarie Simon-Cornu - Centre Hospitalier Régional Universitaire [CHU Lille]Anne Debourgogne - Centre Hospitalier Régional et Universitaire de NancyMarie-Fleur Durieux - Centre Hospitalier Universitaire de LimogesGuillaume Laurent - CHU Dijon BourgogneValérie Bru - Sorbonne UniversitéNathalie Bourgeois - Université de Montpellier, MIVEGEC - Maladies Infectieuses et Vecteurs : Ecologie, Génétique, Evolution et ContrôleKévin Brunet - InsermT. Chouaki - Centre Hospitalier Universitaire Amiens-PicardieAntoine Huguenin - Université de Reims Champagne-ArdenneLilia Hasseine - Hôpital l'ArchetDanièle Maubon - Centre Hospitalier Universitaire de GrenobleJ.P. Gangneux - École des Hautes Études en Santé PubliqueN. Desbois-Nogard - Centre Hospitalier Universitaire de MartiniqueSandrine Houzé - Lyon 1 UniversitéFrédéric Dalle - CHU Dijon BourgogneMarie-Elisabeth Bougnoux - Délégation Paris 5Alexandre Alanio - Sorbonne UniversitéDelphine Costa - Université de Rouen NormandieF. Botterel - Hôpitaux Universitaires Henri-MondorChristophe Hennequin - Inserm
- Journal of Medical Mycology = Journal de Mycologie Médicale, Vol.34(3)
- 99281536209311
- MIVEGEC - Maladies Infectieuses et Vecteurs : Ecologie, Génétique, Evolution et Contrôle
- English
- Journal article
- hal-04675511